Resultados de la búsqueda 211-220 of 4580 for jacalyn see

1. Cirugía - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...

2. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

   albicans and associated with microbial dysbiosis seen in atopic dermitis. We hypothesize presence of C. albicans in the microbial communities in early life is ...

3. Cirugía - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...

4. Cirugía - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

6. Cirugía - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...

7. Cirugía - Ensayos clínicos - Mayo Clinic

   Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. Impact of ...

8. Cirugía - Ensayos clínicos - Mayo Clinic

   Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. Impact of ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. The purpose of this study is to find out more about certain markers of immune suppression in people with kidney tumors (whether the tumors are ...

10. Mayo Clinic Digestive Diseases Physician Update e-Edition, June 2015

    But new drugs targeting different aspects of the signaling cascade that follows liver injury, now in clinical trials, may prove more effective. See all ...